Diasorin Logo

Diasorin

DIA | XMIL

Overview

Corporate Details

ISIN(s):
IT0003492391 (+2 more)
LEI:
8156002878BDF0EE4348
Country:
Italy
Address:
VIA CRESCENTINO, SNC, 13040 SALUGGIA
Sector:
Health Care
Industry:
Biotechnology

Description

World leaders in the lab diagnostics market, we are specialists in the immunodiagnostics and molecular diagnostics segments and active in the Licensed Technology sector The Company has been developing, producing and marketing reagent kits for laboratory diagnostics all over the world, for over 50 years. Our broad offering of diagnostic tests and Licensed Technology solutions, made available thanks to ongoing investments in research, positions us as the player with the widest range of specialty solutions in the sector and identifies the Group as the "Diagnostics Specialist". Diagnosis is the first step towards understanding a person’s state of health. This is why our tests can make the difference: they are precise and reliable and enable delivery of early diagnosis of various pathologies for millions of people who will then be able to receive the most appropriate therapy.

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-05-12 15:37
Proxy Solicitation & Information Statements
Pubbicazione del verbale dell'Assemblea degli Azionisti del 28 aprile 2025
Italian 184.1 KB
2025-05-12 15:26
Declaration of Voting Results & Voting Rights Announcements
Verbale Assemblea Ordinaria degli Azionisti 28 aprile 2025
English 21.1 MB
2025-05-06 17:43
Quarterly Report
Diasorin Q1 2025 Results Presentation
English 1.4 MB
2025-05-06 17:39
Earnings Release
Revenue growing +8% and EBITDA margin at 34%: Q1 Results confirm FY 2025 Guidan…
English 369.9 KB
2025-05-06 17:38
Earnings Release
Ricavi in crescita dell’8% ed EBITDA Margin al 34%: i risultati del 1° trimestr…
Italian 417.5 KB
2025-04-29 12:52
Declaration of Voting Results & Voting Rights Announcements
Shareholders' Meeting April 29, 2025 - Summary report on votes
English 224.5 KB
2025-04-28 18:50
Declaration of Voting Results & Voting Rights Announcements
Pubblicazione del rendiconto sintetico delle votazioni
Italian 188.9 KB
2025-04-28 18:48
Declaration of Voting Results & Voting Rights Announcements
Assemblea degli Azionisti del 28 aprile 2025 - Rendiconto sintetico delle votaz…
Italian 561.9 KB
2025-04-28 16:45
AGM Report
Diasorin S.p.A. - Shareholders' Meeting 2025
English 227.4 KB
2025-04-28 16:41
AGM Report
Assemblea degli Azionisti 2025 - Diasorin S.p.A.
Italian 247.6 KB
2025-04-24 19:35
Annual Report
Annual Financial Report as at December 31, 2024
English 12.8 MB
2025-04-16 18:12
Declaration of Voting Results & Voting Rights Announcements
Communication on total amount of voting rights
English 222.7 KB
2025-04-16 18:10
Declaration of Voting Results & Voting Rights Announcements
Comunicazione dell'ammontare complessivo dei diritti di voto
Italian 222.9 KB
2025-04-07 13:04
Declaration of Voting Results & Voting Rights Announcements
Publication of the lists of candidates for the appointment of the Board Directo…
English 204.5 KB
2025-04-07 13:02
Proxy Solicitation & Information Statements
Pubblicazione delle liste per la nomina del Consiglio di Amministrazione, del C…
Italian 229.0 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo 1NKEMIA Spain IKM
2cureX AB Logo 2cureX AB Sweden 2CUREX
4SC AG Logo 4SC AG Germany VSC
Abera Bioscience AB Logo Abera Bioscience AB Sweden ABERA
ABIONYX Pharma Logo ABIONYX Pharma France ABNX
Abliva Logo Abliva Sweden ABLI
AB Science Logo AB Science France AB
Acticor Biotech Logo Acticor Biotech France ALACT
Active Biotech Logo Active Biotech Sweden ACTI
AcuCort AB Logo AcuCort AB Sweden ACUC